ranQ
ranQ
ranQ
DirectoryIndustriesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The first Swiss company directory, built to boost AI visibility.

Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint744,877 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentZugApellis International GmbH
Apellis International GmbH Logo
Verified· 2 sources

Apellis International GmbH

Summary

About the company

Apellis International GmbH develops medicines that inhibit the complement cascade by targeting the central protein C3. Its products include the C3‑targeting medicines EMPAVELI® and SYFOVRE®, and the company advances clinical and preclinical programs across ophthalmology, hematology, nephrology and gene-/RNA‑based therapeutic approaches.

AI-generated
Offering

Products & services

Industry:Research & Development
✓ Offered5
Therapeutics
Therapeutics for ophthalmological, haematological and nephrological diseases as well as other complement-mediated conditions; including SYFOVRE® (pegcetacoplan injection) and EMPAVELI® (pegcetacoplan).
Clinical trials
Clinical trials in PNH, geographic atrophy, C3 glomerulopathy, IC-MPGN and autoimmune hemolytic anemia; including ongoing, recruiting and completed study programmes.
Research and drug development
Research into complement biology, preclinical and clinical programmes, development of RNA therapies, gene editing and oral complement inhibitors.
Patient support and early access programmes
Patient support for EMPAVELI and SYFOVRE, as well as Compassionate Use and Early Access Programme for therapies that are not available or not approved.
Patient information and advocacy
Information for patients and caregivers, materials on GA and C3G, as well as a contact for patient advocacy and collaboration with patient organisations.
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub

Knowledge

No knowledge articles yet

Once Apellis International GmbH has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Apellis International GmbH in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Apellis International GmbH by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Apellis International GmbH to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Zählerweg 10
6300 Zug
Opening hours
Mon
09:00 - 17:30
Tue
09:00 - 17:30
Wed
09:00 - 17:30
Thu
09:00 - 17:30
Fri
09:00 - 17:30
Sat
Closed
Sun
Closed

At a glance

Legal form
Limited Liability Company
UID
CHE-200.662.403
Founded
2019 · 7 years
Last commercial register change
August 7, 2026
Employees
11 to 20

Similar companies

QA
Qualitas AG
Zug
DA
Dotphoton AG
Zug
FT
FLARM Technology AG
Zug
GS
G&L Scientific (Schweiz) GmbH
Zug